Peptide questions · Exenatide
Exenatide side effects: what studies and users report
Reviewed Evidence: EstablishedPublished by PepVault
The side effects most commonly reported for exenatide are nausea, vomiting and diarrhea, among 8 the library lists; the library’s evidence on it includes controlled trials in people.
Its safety note opens: The Byetta label carries no boxed warning, but in a two-year rat study benign thyroid C-cell tumours were more common in female rats at every dose.
What is commonly reported with exenatide
- Nausea
- Vomiting
- Diarrhea
- Feeling jittery
- Dizziness
- Headache
- Indigestion
- Low blood sugar (with a sulfonylurea or insulin)
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 24) |
|---|---|
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Feeling jittery | None: listed for Exenatide alone |
| Dizziness | 2: Mazdutide, Pramlintide |
| Headache | 3: Setmelanotide, Orforglipron, Pramlintide |
| Indigestion | 2: Dulaglutide, Orforglipron |
| Low blood sugar (with a sulfonylurea or insulin) | 1: Pramlintide |

Model. Individual results vary.
Which exenatide side effects the metabolic & GLP-1 group shares
Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Exenatide shares 7 of its 8 listed effects with at least one other metabolic & GLP-1 compound; feeling jittery is listed for exenatide alone.
What the exenatide safety notes say
The library’s safety note
The Byetta label carries no boxed warning, but in a two-year rat study benign thyroid C-cell tumours were more common in female rats at every dose. Its warnings are acute pancreatitis, including fatal forms seen with GLP-1 drugs; low blood sugar, including severe episodes, when combined with a sulfonylurea or insulin; kidney injury after dehydration from vomiting or diarrhea; severe stomach side effects (it is not recommended with severe gastroparesis, or with severe kidney disease); antibodies that blunted the glucose response in 1 to 4% of trial patients; serious allergic reactions; a rare immune drop in platelets that can cause serious bleeding; gallbladder disease (1.9% vs 1.4% on placebo); and food reaching the lungs under anesthesia. A pen is never shared, even with a new needle. These are label findings; review them with your clinician.
The library’s interaction note
Exenatide slows stomach emptying, so oral medicines can be absorbed more slowly: the label suggests taking drugs that need a steady level, such as contraceptives and antibiotics, at least 1 hour before the shot. Reports of a raised INR on warfarin, sometimes with bleeding, led the label to suggest closer INR checks when exenatide starts or changes. With a sulfonylurea or insulin, the label suggests considering lower doses of those. It is a GLP-1 drug itself, so it is not combined with another one or with another exenatide product. Discuss all your medicines with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the exenatide reports come from
The library rates the evidence on exenatide as established: clinical trials or FDA-approved use exist.
Of the library’s 6 research notes on exenatide, 4 rest on randomized trials, 1 on clinical data and 1 on community reports.
Our 8 study pages on exenatide: 8 randomized trials.
So exenatide has controlled trials in people to set its listed effects against.
What our exenatide study pages report on safety
Exenatide: lower intracranial pressure in IIH over 12 weeks
Randomized trial, human, 2023: No serious safety signals were seen.
Exenatide did not cut heavy drinking days in alcohol use disorder
Randomized trial, human, 2022: In an exploratory look at patients with obesity (BMI > 30 kg/m2), those on exenatide had significantly fewer heavy drinking days and drank less alcohol overall, and side effects were mostly in the gut.
Exenatide ER: 0.9% HbA1c drop vs 1.5% with semaglutide in SUSTAIN 3
Randomized trial, human, 2018: Stomach and gut side effects hit 33.3% on exenatide ER and 41.8% on semaglutide, but reactions where the shot went in showed up in 22.0% of the exenatide ER arm, against 1.2% of the semaglutide arm. Head to head over 56 weeks, exenatide ER 2.0 mg lowered HbA1c and weight less than semaglutide 1.0 mg, with fewer gut side effects but more injection-site reactions.
Exenatide: no significant drop in heart events vs placebo in EXSCEL
Randomized trial, human, 2017: exenatide met the bar for being no worse than placebo on safety (P<0.001), but not for being better (P=0.06). Heart deaths, heart attacks, strokes, heart failure hospital stays, pancreatitis, pancreatic cancer, medullary thyroid cancer and serious side effects did not differ significantly between groups.
Questions people ask
What are the side effects of exenatide?
The side effects most commonly reported for exenatide are nausea, vomiting and diarrhea, among 8 the library lists; the library’s evidence on it includes controlled trials in people.
Do exenatide’s side effects come from human studies?
The library rates the evidence on exenatide as established, and the library’s evidence on it includes controlled trials in people.
Which exenatide side effects are its own?
Among the metabolic & GLP-1 compounds, the library lists feeling jittery for exenatide alone.
Does exenatide interact with other medicines?
The library’s interaction note on exenatide begins: exenatide slows stomach emptying, so oral medicines can be absorbed more slowly: the label suggests taking drugs that need a steady level, such as contraceptives and antibiotics, at least 1 hour before the shot.